Compounds and methods for targeting pathogenic blood vessels
US11884647B2 · kind B2 · utility
0Cited by
53References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 2020 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Mar 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosure provides compounds, and compositions, including pharmaceutical compositions, kits that include the compounds, and methods of using (or administering) and making the compounds. The disclosure further provides compounds or compositions thereof for use in a method of modulating PLXDC1 (TEM7) and/or PLXDC2 or killing pathogenic blood vessles. The disclosure further provides compounds or compositions thereof for use in a method of treating a disease, disorder, or condition that is mediated, at least in part, by PEDF receptors or by angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.